Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

NCT04571151 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: LEXETTE 0.05% Topical Foam
DRUG: Sorilux 0.005 % Topical Foam
OTHER: Vehicle Foam

Sponsor

Skin Sciences, PLLC